Bentham Science Logo

Current Radiopharmaceuticals

Volume 12, 3 Issues, 2019
ISSN: 1874-4729 (Online)
ISSN: 1874-4710 (Print)
This journal supports open access

Aims & Scope

Current Radiopharmaceuticals publishes original research articles, letters, full-length/mini reviews, drug clinical trial studies and guest edited issues on all aspects of research and development of radiolabelled compound preparations, covering studies related to nuclear medicine, molecular imaging, radionuclide therapy, as radiology, oncology and radiotherapy and basic research. The scope of the journal also covers the following areas: radio imaging techniques, therapies; preparation and application of radionuclide compounds including the incorporation of tracer methods used in scientific research and applications.

Current Radiopharmaceuticals

,

Volume 12

-

Number 1



Preface   Open Access

Preface

, 12(1): 1 - 3

Luigi Mansi and Sean L. Kitson


DOI: 10.2174/187447101201190213112330


Review Article



Review Article

[68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications

, 12(1): 11 - 22

Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce and Andrea Ciarmiello*


DOI: 10.2174/1874471012666181212101244


Research Article

Evaluating the Radioprotective Effect of Curcumin on Rat’s Heart Tissues

, 12(1): 23 - 28

Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa


DOI: 10.2174/1874471011666180831101459


Research Article



Research Article   Open Access



Research Article

Synthesis of [18F]FAZA Using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination

, 12(1): 49 - 57

William Sun, Cheryl Falzon, Ebrahim Naimi , Ali Akbari , Leonard I. Wiebe*, Manju Tandon and Piyush Kumar


DOI: 10.2174/1874471011666181019105947


Research Article   Open Access

[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 12(1): 58 - 71

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*


DOI: 10.2174/1874471012666190102165053


Articles Ahead of Print


Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries


Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova


View Abstract View on PubMed


PET/MRI in Neuroendocrine Tumours: Blessings and Curses


P Mapelli, F De Cobelli and M Picchio






Evaluation of the Radioprotective Effects of Melatonin Against Ionizing Radiation-Induced Muscle Tissue Injury


Dheyauldeen Shabeeb, Mansoor Keshavarz , Alireza Shirazi*, Gholamreza Hassanzadeh*, Mohammed Reza Hadian, Azin Nowrouzi, Masoud Najafi* and Ahmed Eleojo Musa


View Abstract View on PubMed






Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience


Laura Evangelista*, Cuppari Lea, Bellu Luisa , Bertin Daniele, Caccese Mario , Reccia Pasquale, Zagonel Vittorina and Lombardi Giuseppe


View Abstract View on PubMed


Abstracts Ahead of Print

68Ga/64Cu PSMA bio-distribution in prostate cancer patients: potential pitfalls for different tracers


Ferdinando Calabria*, Robert Pichler, Mario Leporace, Johannes Wolfsgruber, Pierluigi Coscarelli, Andreas Dunzinger, Orazio Schillaci, Giuseppe Lucio Cascini and Antonio Bagnato


View Abstract


Editor's Choice

[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 2019; 12(1): 58 - 71

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*


DOI: 10.2174/1874471012666190102165053





Ga-68 Nanoparticles and Ultra-small Nanoparticle: Next Generation of PET Radiopharmaceuticals?

, 2018; 11(2): 123 - 129

Mohammed Al-Qahtani, Yousif Al Malki, Hadeel Mutwali, Edward Helal-Neto and Ralph Santos-Oliveira*


DOI: 10.2174/1874471011666180418110206



Mechanisms of Radiation Bystander and Non-Targeted Effects: Implications to Radiation Carcinogenesis and Radiotherapy

, 2018; 11(1): 34 - 45

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130




PET/MR Tomographs: A Review with Technical, Radiochemical and Clinical Perspectives

, 2017; 10(3): 184 - 194

Giampiero Giovacchini, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello*


DOI: 10.2174/1874471010666170816125051



β -[18F]Fluoro Azomycin Arabinoside (β -[18F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors

, 2017; 10(2): 93 - 101

Piyush Kumar*, Peter Roselt, Gerald Reischl, Carlene Cullinane, Davood Beiki, Walter Ehrlichmann, David Binns, Ebrahim Naimi, Jennifer Yang, Rodney Hicks, Hans-Juergen Machulla and Leonard I. Wiebe


DOI: 10.2174/1874471010666170313120540



Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer


DOI: 10.2174/1874471010666170621122221



177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma

, 2017; 10(1): 21 - 28

Ximena Camacho, Victoria Calzada, Marcelo Fernandez, Omar Alonso, Roger Chammas, Eloisa Riva, Juan Pablo Gambini and Pablo Cabral


DOI: 10.2174/1874471009666161010155246



Open Access Articles

[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 2019; 12(1): 58 - 71

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*




Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

, 2019; 12(1): 40 - 48

Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler




State of the Art and Recent Developments of Radiopharmaceuticals for Pancreatic Neuroendocrine Tumors Imaging

, 2019; 12: 1 - 19 (E-Pub Ahead of Print)

Angela Carollo*, Stefano Papi, Chiara M. Grana, Luigi Mansi and Marco Chinol




Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing Countries

, 2019; 12: 1 - 14 (E-Pub Ahead of Print)

Efrain Araujo Perini *, Mikhail Skopchenko, Tran Thu Hong , Rahmat Harianto , Alexis Maître, Maidelys Rosa Rodríguez Rodríguez , Nathalia de Oliveira Santos , Yinglei Guo, Xiangyu Qin , Carlos A. Zeituni and Valeriia N. Starovoitova




An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200 - 208

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer




Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156 - 172

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*




Synthesis of [18F]2B-SRF101: A Sulfonamide Derivative of the Fluorescent Dye Sulforhodamine 101

, 2017; 10(3): 212 - 220

Ingrid Kreimerman, Williams Porcal, Silvia Olivera, Patricia Oliver, Eduardo Savio* and Henry Engler




Automated One-pot Radiosynthesis of [11C]S-adenosyl Methionine

, 2017; 10(3): 203 - 211

Florencia Zoppolo, Williams Porcal, Patricia Oliver, Eduardo Savio* and Henry Engler




Experiences with 99mTc-HMPAO in a Diagnostic Pathway for Violent Patients with Schizophrenic Spectrum Disorders

, 2017; 10(2): 115 - 122

Morten Jacobsen*, Arvid Jensen, Guttorm Breivik Storvestre, Tone Marie Bergstrom, Diyar Nori Mohamad Rashi, Bjorn Nielssen , Pal Wiktor and Knut-Erik Hymer




Gallium-68 in Medical Imaging

, 2016; 9(3): 187 - 207

Lucia Martiniova, Louis De Palatis, Elba Etchebehere and Gregory Ravizzini




Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

, 2013; 6(1): 20 - 27

Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann and Jostein Dahle




Targeted α-Particle Therapy: A Clinical Overview

, 2008; 1(3): 251 - 253

Massimo Salvatori, Luca Indovina and Luigi Mansi




Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy

, 2008; 1(3): 203 - 208

Oyvind S. Bruland, Thora J. Jonasdottir, Darrell R. Fisher and Roy H. Larsen




Increased [11C]Choline Uptake in Bronchioloalveolar Cell Carcinoma with Negative [18F]FDG Uptake. A PET/CT and Pathology Study

, 2008; 1(2): 62 - 64

Maria Picchio, C. Messa, B. Giglioni, F. Sanvito, E. Caporizzo, C. Landoni, G. Arrigoni, A. Carretta, R. Nicoletti, P. Zannini, A. Del Maschio and F. Fazio




Asymmetric Synthesis of L-[3-13C]Tryptophan

, 2008; 1(2): 122 - 124

Kazuhiko Takatori, Myonghui Lee and Masahiro Kajiwara





Most Cited Articles

Review Article

Mechanisms of radiation bystander and non-targeted effects: Implications to radiation carcinogenesis and radiotherapy

, 2018; 11(1): 34-45.

Rasoul Yahyapour, Elahe Motevaseli, Abolhasan Rezaeyan, Hamid Abdollahi, Bagher Farhood, Mohsen Cheki, Masoud Najafi* and Vilmar Villa


DOI: 10.2174/1874471011666171229123130


Review Article

An overview of targeted alpha therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524


Review Article

The production of Ac-225

, 2018; 11(3): 173-179.

Jonathan W. Engle*


DOI: 10.2174/1874471011666180418141357


Review Article

Radiopharmaceuticals labelled with copper radionuclides: Clinical results in human beings

, 2018; 11(1): 22-33.

Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore


DOI: 10.2174/1874471011666171211161851


Review Article

Dosimetry and radiobiology of alpha-particle emitting radionuclides

, 2018; 11(3): 209-214.

George Sgouros*, Robert Hobbs and Anders Josefsson


DOI: 10.2174/1874471011666180426130058


Research Article

In vivo evaluation of [ <sup>225</sup> Ac]Ac-DOTA <sup>ZOL</sup> for α-therapy of bone metastases

, 2018; 11(3): 223-230.

Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*


DOI: 10.2174/1874471011666180604083911


Review Article

Review: The role of radiolabeled DOTA-conjugated peptides for imaging and treatment of childhood neuroblastoma

, 2018; 11(1): 14-21.

Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*


DOI: 10.2174/1874471011666171215093112



Research Article

Automated synthesis of <sup>68</sup>Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations

, 2018; 11(2): 130-137.

Licia Uccelli*, Alessandra Boschi, Corrado Cittanti, Petra Martini, Luca Lodi, Elisa Zappaterra, Simona Romani, Samanta Zaccaria, Davide Cecconi, Ilaria Rambaldi, Ivan Santi, Stefano Panareo, Melchiore Giganti and Mirco Bartolomei


DOI: 10.2174/1874471011666180509101420


Review Article

PET/CT with <sup>68</sup>Ga-PSMA in prostate cancer: Radiopharmaceutical background and clinical implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello


DOI: 10.2174/1874471010666171101121803



Review Article

Development of <sup>225</sup> ac radiopharmaceuticals: TRIUMF perspectives and experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908


Research Article

In vivo evaluation of free and chelated accelerator-produced Actinium-225-radiation dosimetry and toxicity results

, 2018; 11(3): 215-222.

Zewei Jiang, Ekaterina Revskaya, Darrell R. Fisher and Ekaterina Dadachova*


DOI: 10.2174/1874471011666180423120707



Research Article

Quantification of radiation exposure of non-dominant index for the surgeon performing sentinel lymph-node removal procedure

, 2018; 11(1): 64-68.

Claudiu Pestean*, Maria Iulia Larg, Elena Barbus, Claudiu Badulescu and Doina Piciu


DOI: 10.2174/1874471011666180206165744



Most Accessed Articles

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524


[68Ga]-Dota Peptide PET/CT in Neuroendocrine Tumors: Main Clinical Applications

, 2019; 12(1): 11-22.

Elisabetta Giovannini, Giampiero Giovacchini, Elisa Borsò, Patrizia Lazzeri, Mattia Riondato, Rossella Leoncini, Valerio Duce and Andrea Ciarmiello*


DOI: 10.2174/1874471012666181212101244


Dosimetry and Toxicity Studies of the Novel Sulfonamide Derivative of Sulforhodamine 101([18F]SRF101) at a Preclinical Level

, 2019; 12(1): 40-48.

Ingrid Kreimerman, Erick Mora-Ramirez, Laura Reyes, Manuel Bardiès, Eduardo Savio* and Henry Engler


DOI: 10.2174/1874471011666180830145304



Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908


[18F]Amylovis as a Potential PET Probe for β-Amyloid Plaque: Synthesis, In Silico, In vitro and In vivo Evaluations

, 2019; 12(1): 58-71.

Suchitil Rivera-Marrero, Laura Fernández-Maza, Samila León-Chaviano, Marquiza Sablón-Carrazana, Alberto Bencomo-Martínez, Alejandro Perera-Pintado, Anais Prats-Capote, Florencia Zoppolo, Ingrid Kreimerman, Tania Pardo, Laura Reyes, Marcin Balcerzyk, Geyla Dubed-Bandomo, Daymara Mercerón-Martínez, Luis A. Espinosa-Rodríguez, Henry Engler, Eduardo Savio* and Chryslaine Rodríguez-Tanty*


DOI: 10.2174/1874471012666190102165053



PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello


DOI: 10.2174/1874471010666171101121803


Evaluating the Radioprotective Effect of Curcumin on Rat’s Heart Tissues

, 2019; 12(1): 23-28.

Sedighe Kolivand, Peyman Amini, Hana Saffar, Saeed Rezapoor, Elahe Motevaseli*, Masoud Najafi*, Farzad Nouruzi, Dheyauldeen Shabeeb and Ahmed Eleojo Musa


DOI: 10.2174/1874471011666180831101459



Related Journals

Related eBooks

eBooks Catalog